{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T03:45:01Z","timestamp":1773632701179,"version":"3.50.1"},"reference-count":39,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,10,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Adding synthetic oligodeoxynucleotides containing unmethylated CpG motifs to Anthrax vaccine adsorbed (AVA, the licensed human vaccine) increases the speed and magnitude of the resultant Ab response. Ab titers persist in the protective range for &amp;gt;1 year, significantly longer than in animals vaccinated with AVA alone. Unexpectedly, a majority of mice immunized with CpG-adjuvanted AVA maintained resistance to anthrax infection even after their Ab titers had declined into the subprotective range. The survival of these animals was mediated by the de novo production of protective Abs by high affinity memory B cells re-stimulated immediately after challenge. Thus, a previously unrecognized benefit of CpG oligodeoxynucleotides adjuvants is their ability to expand the long-lived memory B cell population. Current findings demonstrate that CpG-adjuvanted AVA mediates protection both by stimulating a strong\/persistent serum Ab response and by generating a high-affinity long-lived pool of memory B cells.<\/jats:p>","DOI":"10.4049\/jimmunol.181.8.5785","type":"journal-article","created":{"date-parts":[[2014,4,18]],"date-time":"2014-04-18T19:47:01Z","timestamp":1397850421000},"page":"5785-5790","source":"Crossref","is-referenced-by-count":41,"title":["Effect of CpG Oligonucleotides on Vaccine-Induced B Cell Memory"],"prefix":"10.1093","volume":"181","author":[{"given":"Debra","family":"Tross","sequence":"first","affiliation":[{"name":"National Cancer Institute , Frederick, MD 21702"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dennis M","family":"Klinman","sequence":"additional","affiliation":[{"name":"National Cancer Institute , Frederick, MD 21702"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2008,10,15]]},"reference":[{"key":"2026012807142258200_R1","first-page":"13","article-title":"Anthrax pathogenesis and host response","volume-title":"Curr. Top. Microbiol. Immunol.","year":"1998"},{"key":"2026012807142258200_R2","first-page":"566","article-title":"A cloned polyoma DNA fragment representing the 5\u2032 half of the early gene region is oncogenic","volume-title":"J. Virol.","year":"1980"},{"key":"2026012807142258200_R3","first-page":"131","article-title":"Molecular pathogenesis of Bacillus anthracis infection","volume-title":"Microbes Infect.","year":"1999"},{"key":"2026012807142258200_R4","first-page":"1677","article-title":"The role of antibodies to Bacillus anthracis and anthrax toxin components in inhibiting the early stages of infection by anthrax spores","volume-title":"Microbiology","year":"2001"},{"key":"2026012807142258200_R5","first-page":"127","article-title":"Comparative safety and efficacy against Bacillus anthracis of protective antigen and live vaccines in mice","volume-title":"Microb. Pathog.","year":"1988"},{"key":"2026012807142258200_R6","first-page":"729","article-title":"Anthrax. S. A. Plotkin, and E. A. Mortimer, eds","volume-title":"Vaccines","year":"1998"},{"key":"2026012807142258200_R7","first-page":"12","article-title":"Recent advances in the development of an improved, human anthrax vaccine","volume-title":"Eur. J. Epidemiol.","year":"1988"},{"key":"2026012807142258200_R8","first-page":"972","article-title":"Anthrax vaccine: short-term safety experience in humans","volume-title":"Vaccine","year":"2001"},{"key":"2026012807142258200_R9","first-page":"632","article-title":"Field evaluation of a human anthrax vaccine","volume-title":"Am. J. Public Health Nations Health","year":"1962"},{"key":"2026012807142258200_R10","first-page":"112","article-title":"US soldiers refuse to fall in line with anthrax vaccination scheme","volume-title":"Nat. Med.","year":"2004"},{"key":"2026012807142258200_R11","first-page":"217","article-title":"Anthrax vaccination and joint related adverse reactions in light of biological warfare scenarios","volume-title":"Clin. Exp. Rheumatol.","year":"2002"},{"key":"2026012807142258200_R12","first-page":"1271","article-title":"Bioterrorism: a clear and present danger","volume-title":"Nat. Med.","year":"2001"},{"key":"2026012807142258200_R13","first-page":"828","article-title":"CpG oligodeoxynucleotides adsorbed onto polylactide-co-glycolide microparticles improve the immunogenicity and protective activity of the licensed anthrax vaccine","volume-title":"Infect. Immun.","year":"2005"},{"key":"2026012807142258200_R14","first-page":"1478","article-title":"Systemic but not mucosal immunity induced by AVA prevents inhalational anthrax","volume-title":"Microbes Infect.","year":"2007"},{"key":"2026012807142258200_R15","first-page":"137","article-title":"CpG oligonucleotides improve the protective immune response induced by the licensed anthrax vaccine","volume-title":"Ann. NY Acad. Sci.","year":"2006"},{"key":"2026012807142258200_R16","first-page":"546","article-title":"CpG motifs in bacterial DNA trigger direct B-cell activation","volume-title":"Nature","year":"1995"},{"key":"2026012807142258200_R17","first-page":"2879","article-title":"CpG motifs expressed by bacterial DNA rapidly induce lymphocytes to secrete IL-6, IL-12, and IFNg","volume-title":"Proc. Natl. Acad. Sci. USA","year":"1996"},{"key":"2026012807142258200_R18","first-page":"3555","article-title":"Cutting edge: role of toll-like receptor 9 in CpG DNA-induced activation of human cells","volume-title":"J. Immunol.","year":"2001"},{"key":"2026012807142258200_R19","first-page":"740","article-title":"A Toll-like receptor recognizes bacterial DNA","volume-title":"Nature","year":"2000"},{"key":"2026012807142258200_R20","first-page":"1840","article-title":"Induction of NK activity in murine and human cells by CpG motifs in oligodeoxynucleotides and bacterial DNA","volume-title":"J. Immunol.","year":"1996"},{"key":"2026012807142258200_R21","first-page":"72","article-title":"Bacterial DNA induces murine interferon-\u03b3 production by stimulation of IL-12 and tumor necrosis factor-\u03b1","volume-title":"Cell. Immunol.","year":"1996"},{"key":"2026012807142258200_R22","first-page":"1141","article-title":"Comparative efficacy of experimental anthrax vaccine candidates against inhalation anthrax in rhesus macaques","volume-title":"Vaccine","year":"1998"},{"key":"2026012807142258200_R23","first-page":"303","article-title":"Immunization against anthrax with aromatic compound-dependent (Aro-) mutants of Bacillus anthracis and with recombinant strains of Bacillus subtilis that produce anthrax protective antigen","volume-title":"Infect. Immun.","year":"1990"},{"key":"2026012807142258200_R24","first-page":"4420","article-title":"Complement depletion renders C57BL\/6 mice sensitive to the Bacillus anthracis Sterne strain","volume-title":"Infect. Immun.","year":"2005"},{"key":"2026012807142258200_R25","first-page":"2881","article-title":"CpG oligonucleotides improve the protective immune response induced by the anthrax vaccination of rhesus macaques","volume-title":"Vaccine","year":"2004"},{"key":"2026012807142258200_R26","first-page":"LB-25","article-title":"Marked enhancement of antibody response to anthrax vaccine adsorbed with CpG 7909 in healthy volunteers","volume-title":"Interscience Conference on Antimicrobial Agents and Chemotherapy","year":"2005"},{"key":"2026012807142258200_R27","first-page":"241","article-title":"The mechanism of antigenic stimulation of primary and secondary clonal precursor cells","volume-title":"J. Exp. Med.","year":"1972"},{"key":"2026012807142258200_R28","first-page":"1338","article-title":"The stimulation of splenic foci in vitro","volume-title":"J. Immunol.","year":"1971"},{"key":"2026012807142258200_R29","first-page":"3147","article-title":"The affinity threshold for antigenic triggering differs for tolerance susceptible immature precursors vs mature primary B cells","volume-title":"J. Immunol.","year":"1986"},{"key":"2026012807142258200_R30","first-page":"324","article-title":"Combination of microneutralization and avidity assays: improved diagnosis of recent primary human cytomegalovirus infection in single serum sample of second trimester pregnancy","volume-title":"J. Med. Virol.","year":"2000"},{"key":"2026012807142258200_R31","first-page":"32","article-title":"Estimation of the avidity of immunoglobulin G for routine diagnosis of chronic Toxoplasma gondii infection in pregnant women","volume-title":"Eur. J. Clin. Microbiol. Infect. Dis.","year":"1998"},{"key":"2026012807142258200_R32","first-page":"201","article-title":"Use of CpG oligodeoxynucleotides as immune adjuvants","volume-title":"Immunol. Rev.","year":"2004"},{"key":"2026012807142258200_R33","first-page":"135","article-title":"Adjuvant activity of CpG oligodeoxynucleotides","volume-title":"Int. Rev. Immunol.","year":"2006"},{"key":"2026012807142258200_R34","first-page":"2045","article-title":"Bacterial DNA and immunostimulatory CpG oligonucleotides trigger maturation and activation of murine dendritic cells","volume-title":"Eur. J. Immunol.","year":"1998"},{"key":"2026012807142258200_R35","first-page":"2617","article-title":"CpG oligodeoxynucleotides induce human monocytes to mature into functional dendritic cells","volume-title":"Eur. J. Immunol.","year":"2002"},{"key":"2026012807142258200_R36","first-page":"394","article-title":"Immunological correlates for protection against intranasal challenge of Bacillus anthracis spores conferred by a protective antigen-based vaccine in rabbits","volume-title":"Infect. Immun.","year":"2006"},{"key":"2026012807142258200_R37","first-page":"2888","article-title":"Search for correlates of protective immunity conferred by anthrax vaccine","volume-title":"Infect. Immun.","year":"2001"},{"key":"2026012807142258200_R38","first-page":"422","article-title":"Defining a serological correlate of protection in rabbits for a recombinant anthrax vaccine","volume-title":"Vaccine","year":"2004"},{"key":"2026012807142258200_R39","first-page":"125","article-title":"Efficacy of a standard human anthrax vaccine against Bacillus anthracis aerosol spore challenge in rhesus monkeys","volume-title":"Salisbury Med. Bull.","year":"1985"}],"container-title":["The Journal of Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/181\/8\/5785\/62583284\/7893.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/181\/8\/5785\/62583284\/7893.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T12:17:32Z","timestamp":1769602652000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jimmunol\/article\/181\/8\/5785\/8009249"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10]]},"references-count":39,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2008,10,15]]},"published-print":{"date-parts":[[2008,10,15]]}},"URL":"https:\/\/doi.org\/10.4049\/jimmunol.181.8.5785","relation":{},"ISSN":["1550-6606","0022-1767"],"issn-type":[{"value":"1550-6606","type":"electronic"},{"value":"0022-1767","type":"print"}],"subject":[],"published-other":{"date-parts":[[2008,10]]},"published":{"date-parts":[[2008,10]]}}}